MARIO
FERNANDEZ FRAGA
Profesor Asociado
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (10)
2023
-
Nicotinamide N-methyltransferase (NNMT) regulates the glucocorticoid signaling pathway during the early phase of adipogenesis
Scientific Reports, Vol. 13, Núm. 1
-
The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent
Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 878-895
2019
-
Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program
Acta Neuropathologica, Vol. 138, Núm. 6, pp. 1053-1074
2018
-
MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis
Cell Death and Disease, Vol. 9, Núm. 10
2014
-
S-adenosylmethionine levels regulate the schwann cell DNA methylome
Neuron, Vol. 81, Núm. 5, pp. 1024-1039
2013
-
A DNA methylation signature associated with the epigenetic repression of glycine N-methyltransferase in human hepatocellular carcinoma
Journal of Molecular Medicine, Vol. 91, Núm. 8, pp. 939-950
2010
-
Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide
Hepatology, Vol. 52, Núm. 1, pp. 105-114
-
Sirtuin 1 regulation of developmental genes during differentiation of stem cells
Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, Núm. 31, pp. 13736-13741
2009
-
Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect
Oncogene, Vol. 28, Núm. 6, pp. 781-791
2008
-
Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice
Hepatology, Vol. 47, Núm. 4, pp. 1191-1199